BUSINESS
Is Eris Lifesciences the correct prescription for you?
BUSINESS
GST Watch: In staples and durables, expect two quarters of supply disruption
BUSINESS
Why this midcap company could be spinning its way to the top
BUSINESS
Bumpy ride for commercial vehicle companies far from over
BUSINESS
Do FIIs and DIIs really drive the markets? Here’s what correlations say
BUSINESS
Key lesson from FY17 IPOs: Don’t fret if you miss the bus





